NCT02732093

UnknownPhase 2

Does Stellate Ganglion Block Decrease Stress Response of Int...

Assiut University Source

Compare

Other study identifiers

Sponsor study identifier

irb00008718/654

Study Type

interventional

Estimated enrollment

60

Locations

1 country

Sites

1

Timeline

Study Start

April 2016

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2016

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 2016

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

In this study investigators will evaluate the effect of stellate ganglion block on stress response of intubation in comparison to traditional antistress measures in adult patients

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 60 participants
Study completion date: July 2016
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 2016
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
April 5, 2016
Actual (reported)
First Posted
April 8, 2016
Actual (reported)
Primary Completion
July 2016
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2016
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: April 8, 2016
Status Verified: April 2016
Last Update Submitted: April 7, 2016

Conditions

Intubation Stellate Ganglion

Outcome Measures

Primary Outcomes (1)

heart rate
measured in beat/min.
5 minutes

Secondary Outcomes (1)

mean arterial blood pressure
5 minutes

Study Arms (2)

stellate block

ACTIVE COMPARATOR

patients in this arm will receive ultrasonographic guided left stellate block with 6 ml of lidocaine 2% after routine induction of general anesthesia and before endotracheal intubation

Procedure: stellate blockDrug: lidocaine 2%

control

PLACEBO COMPARATOR

patients in this arm will receive ultrasonographic guided left stellate block with 6 ml normal saline (Na.Cl 0.9%) (control group) after routine induction of general anesthesia and before endotracheal intubation

Procedure: stellate blockDrug: Na.Cl 0.9% (placebo)

Interventions

stellate blockProcedure

Also known as: cervicothoracic ganglion block

controlstellate block

Na.Cl 0.9% (placebo)Drug

control

Eligibility Criteria

Age18 Years - 60 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64)

You may qualify if:

Elective surgery
General anesthesia with endotracheal intubation

Sponsors & Collaborators

Assiut University
Otherlead

Study Sites (1)

Assiut University hospitals

Asyut, Asyut Governorate, 71515, Egypt

abdelraheem Elawamy, MDCONTACT00201000032655 arawamyyy@yahoo.com

Study Officials

abdelraheem Elawamy, MD
Assiut University
PRINCIPAL INVESTIGATOR

Central Study Contacts

Abdelraheem Elawamy, MD

CONTACT

00201000032655 arawamyyy@yahoo.com

Study Design

Study Type: interventional
Phase: phase 2
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
Purpose: PREVENTION
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: lecturer

Study Record Dates

First Submitted

April 5, 2016

First Posted

April 8, 2016

Study Start

April 2016

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2016

NCT04634656

Lidocaine on Early Cognitive Dysfunction in Shoulder Arthroscopy

Phase 2Unknown

NCT02763592

Impact of 5% Lidocaine Medicated Plaster on Allodynic Symptoms of Localized Neuropathic Pain After Knee Surgery

Phase 2Completed

NCT03430531

Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Phase 2Terminated

NCT06109389

The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache

Phase 2Unknown

NCT06433713

Effect of Intraoperative Intravenous Lidocaine on Postoperative Pain and Return of Bowel Function After Cesarean Sections

Phase 2Completed

NCT05365880

Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache

Phase 2Withdrawn

lidocaine 2%Drug

stellate block

ASA I/II

You may not qualify if:

Pregnancy
Hypersensitivity to local anesthetics
Coagulopathy
Infection at site of injection
Patient refusal

Contact the study team to confirm eligibility.

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 2016

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

April 8, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing: Will share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02732093
Data provider: ClinicalTrials.gov
Source updated: 2016-04-08
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:09 UTC

Locations

EG(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

stellate block

control

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations